Search Results 611-620 of 17146 for monoclonal antibody
... monoclonal antibody is deemed appropriate). • Recommendation by the treating provider to initiate therapy with a commercially available, FDA approved, anti ...
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...
The development of trastuzumab in the early 2000s as an antibody-based targeted therapeutic for HER2+ breast cancer heralded a new era of precision medicine in ...
Prior treatment with a monoclonal antibody within 30 days of receiving the first dose of study drugs. Prior BCMA targeted therapy. Evidence of active ...
Your healthcare professional also might recommend monthly injections of a calcitonin gene-related peptide monoclonal antibody. The injections may help ...
This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...
Physicians at Mayo Clinic have used rituximab, a monoclonal antibody directed against the CD20 antigen on the surface of B lymphocytes, to treat patients with ...
Myelin oligodendrocyte glycoprotein antibody-associated disease, also known as MOGAD, is a rare inflammatory disease that affects the central nervous system. In ...
The purpose of this study is to determine the prevalence, diagnostic accuracy and predictors of antinueronal antibody positivity in serum and cerebrospinal ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.